Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes
NCT ID: NCT04566588
Last Updated: 2024-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2020-06-25
2021-05-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)
NCT03768765
Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates
NCT04560907
Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP)
NCT01108367
En-bloc With Early Apical Release Versus Lobe-by-lobe LASER Enucleation of the Prostate
NCT07014969
Evaluation of the Effects of Different Prostate Surgeries on Urinary and Sexual Function
NCT01810068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early apical release holmium enucleation of the prostate
Early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia
EAR HoLEP
early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia
Classic holmium enucleation of the prostate
Classic holmium enucleation of the prostate (HoLEP), as a surgical treatment for benign prostatic hyperplasia
Classic HoLEP
classic holmium enucleation of the prostate as a surgical treatment for benign prostatic hyperplasia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EAR HoLEP
early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia
Classic HoLEP
classic holmium enucleation of the prostate as a surgical treatment for benign prostatic hyperplasia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must present to clinic with a diagnosis of benign prostatic hyperplasia
* Patients must be scheduled to undergo a holmium laser enucleation of the prostate
Exclusion Criteria
* Patients with prostate biopsy revealing high risk prostate cancer
* Patients with a concomitant neurogenic bladder diagnosis (SCI, Parkinson, MS, cerebral palsy)
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Don Neff, MD, FACS
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Health System
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
145490
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.